Company: LRHC
Filing Date: 2025-12-04
Form Type: DEF 14C
Source: 0001213900-25-118073
Chunk: 10

Company: La Rosa Holdings Corp.
Filing Date: 2025-12-04
Form: DEF 14C
Chunk 10
---
, and the Company issuing to an Investor certain Token
Rights.

At the Initial Closing, the Company expects to issue an initial Note
in an aggregate principal amount of $11,000,000 upon the satisfaction or waiver of certain closing conditions. Subject to certain other
conditions described in the Securities Purchase Agreement, the Company has the option to request that the Investors purchase additional
Notes (the “Company’s Option Closing”), and the Investor(s) have the option to cause the Company to sell additional
Notes (the “Investor’s Option Closing” and together with the Company’s Option Closing the “Additional Closings” and together with the Initial Closing, each a “Closing”), provided that the aggregate original
principal amount of any Notes issued in: (i) any Company Option Closing may not exceed $5,000,000 individually, (ii) all Additional Closings
may not exceed $239,000,000, and (iii) no Additional Closing may occur after the seven (7) year anniversary of the Initial Closing Date
(or such earlier date as the Investors shall determine, in their sole discretion, as the case may be, the “Additional Closing Expiration Date”). The purchase price for each Note will be $900 for each $1,000 of principal amount of Additional Notes.

At any time during the Covenant
Period (as defined in the Securities Purchase Agreement), the Company will be prohibited from effecting or entering into an agreement
to effect any Subsequent Placement (as defined in the Securities Purchase Agreement) involving a Variable Rate Transaction (as defined
in the Securities Purchase Agreement) without the written consent of the Lead Buyer in its sole discretion. For a period of time ending
the later of (i) the second anniversary of the Securities Purchase Agreement, and (ii) the later of (x) the last date of any Closing (the
date of any Closing, a “Closing Date”) thereunder and (y) the date no Notes remain outstanding, the Investors have
the right to participate up to 40% of in any financing of the Company on the same terms as such other investor(s). The Company also agreed
to reimburse the Lead Buyer for the fees and expenses of its legal counsel and other out-of-pocket expenses.

The Securities Purchase Agreement includes customary representations,
warranties and covenants by the Company and standard closing conditions. The Securities Purchase Agreement also requires that the Company
obtain the Stockholder Approval by the Stockholder Meeting Deadline (as defined therein).

On the Signing Date in